BRA
BIIB icon

Bender Robert & Associates’s Biogen BIIB Stock Holding History

Bender Robert & Associates’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-9,342
Closed -$2.21M – 50
2019
Q1 		$2.21M Sell
9,342
-450
-5% -$142K 1.08% 26
2018
Q4 		$2.95M Sell
9,792
-72
-0.7% -$23K 1.7% 22
2018
Q3 		$3.48M Hold
9,864
– – 1.59% 23
2018
Q2 		$2.86M Buy
9,864
+31
+0.3% +$8.72K 1.5% 23
2018
Q1 		$2.69M Buy
9,833
+349
+4% +$108K 1.5% 24
2017
Q4 		$3.02M Sell
9,484
-117
-1% -$37.5K 1.67% 24
2017
Q3 		$3.01M Buy
9,601
+266
+3% +$78.8K 1.73% 23
2017
Q2 		$2.53M Buy
9,335
+99
+1% +$26.2K 1.55% 22
2017
Q1 		$2.52M Sell
9,236
-222
-2% -$62.8K 1.63% 22
2016
Q4 		$2.68M Sell
9,458
-423
-4% -$125K 1.9% 21
2016
Q3 		$3.09M Buy
9,881
+569
+6% +$169K 2.04% 21
2016
Q2 		$2.25M Sell
9,312
-219
-2% -$57.7K 1.59% 23
2016
Q1 		$2.48M Sell
9,531
-112
-1% -$29.6K 1.68% 24
2015
Q4 		$2.95M Sell
9,643
-1,418
-13% -$407K 1.89% 20
2015
Q3 		$3.23M Sell
11,061
-71
-0.6% -$23.4K 2.18% 19
2015
Q2 		$4.5M Buy
11,132
+86
+0.8% +$34.5K 2.67% 15
2015
Q1 		$4.66M Buy
+11,046
New +$4.35M 2.72% 16

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bender Robert & Associates's BIIB Position: Q2 2019 in Review

Bender Robert & Associates sold out of Biogen (BIIB) in Q2 2019, closing a stake of 9,342 shares — an estimated $2.21M sold.

Bender Robert & Associates first reported a position in BIIB in Q1 2015 and held it in 17 quarters. The position peaked at $4.66M in Q1 2015. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Bender Robert & Associates reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Bender Robert & Associates sold 9,342 Biogen shares in Q2 2019, an estimated $2.21M.
  • Bender Robert & Associates first reported a position in Biogen in Q1 2015 and held it in 17 quarters.
  • Bender Robert & Associates's Biogen position peaked at $4.66M in Q1 2015.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Bender Robert & Associates's 13F filing for Q2 2019, filed 30 Jul 2019.